At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,040 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
In Brief
An observational study for Deep Venous Thrombosis and 2 related conditions. Completed, enrolled 2,040 participants across 18 sites in 5 countries.
Detailed Summary
The purpose of this study is to demonstrate the ability of STA® Liatest® D-Di combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thrombosis (DVT) in a 3 month follow-up.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDeep Venous Thrombosis, Pulmonary Embolism, D-dimer
CountriesCanada, France, Italy, Spain, United States
CollaboratorsUniversity Hospital, Grenoble
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 2010
Enrollment StartNov 2011
Primary CompletionMar 2016
Study CompletionApr 2016
TodayJul 2026
First PostedOct 15, 2010
Enrollment StartNov 1, 2011
Primary CompletionMar 1, 2016
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 15.7 years ago